| Grade 2 Follicular Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived77 of 77show fewer |
|---|
| → investigated in trials for | Rituximabmonoclonal antibody 39 trials (5 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Grade 2 Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |